188 related articles for article (PubMed ID: 3911464)
1. Immunotherapeutic agents: their role in cellular immunity and their therapeutic potential.
Chirigos MA; Talmadge JE
Springer Semin Immunopathol; 1985; 8(4):327-46. PubMed ID: 3911464
[No Abstract] [Full Text] [Related]
2. Bacillus Calmette-Guérin as an anti-tumor agent. The interaction with cells of the mammalian immune system.
Davies M
Biochim Biophys Acta; 1982 Apr; 651(2-3):143-74. PubMed ID: 7046801
[No Abstract] [Full Text] [Related]
3. New strategies of immunotherapy.
Hadden JW; Spreafico F
Springer Semin Immunopathol; 1985; 8(4):321-6. PubMed ID: 2418518
[No Abstract] [Full Text] [Related]
4. Biologicals and biological response modifiers: fourth modality of cancer treatment.
Oldham RK
Cancer Treat Rep; 1984 Jan; 68(1):221-32. PubMed ID: 6198081
[TBL] [Abstract][Full Text] [Related]
5. Cancer active immunotherapy. Immunoprophylaxis and immunorestoration. An introduction.
Mathé G
Recent Results Cancer Res; 1976; 55():1-402. PubMed ID: 1087040
[No Abstract] [Full Text] [Related]
6. New approaches to immunotherapy: thymomimetic drugs.
Specter S; Hadden JW
Springer Semin Immunopathol; 1985; 8(4):375-85. PubMed ID: 3879015
[No Abstract] [Full Text] [Related]
7. [Current therapy: immunopharmaceuticals].
Mahrle G
Z Hautkr; 1987 May; 62(10):753-6, 759-62, 765. PubMed ID: 2887076
[TBL] [Abstract][Full Text] [Related]
8. The immunology of ageing.
Ford PM
Clin Rheum Dis; 1986 Apr; 12(1):1-10. PubMed ID: 3522079
[No Abstract] [Full Text] [Related]
9. [Effect of thymarin on hemostasis and immunogenesis in humans].
Kuznik BI; Morozov VG; Khavinson VKh; Budazhabon GB; Budazhabon NG
Farmakol Toksikol; 1982; 45(3):69-72. PubMed ID: 6980143
[No Abstract] [Full Text] [Related]
10. [Various functions of a dual immunity system].
Göing H
Arzneimittelforschung; 1974 May; 24(5):819-29. PubMed ID: 4211741
[No Abstract] [Full Text] [Related]
11. Fatal disseminated BCG infection. An investigation of the immunodeficiency.
Passwell J; Katz D; Frank Y; Spirer Z; Cohen BE; Ziprkowski M
Am J Dis Child; 1976 Apr; 130(4):433-6. PubMed ID: 773173
[TBL] [Abstract][Full Text] [Related]
12. [The immune system: hormones and mediators].
Petrov RV; Mikhaĭlova AA; Zakharova LA
Probl Endokrinol (Mosk); 1985; 31(5):13-20. PubMed ID: 3877928
[TBL] [Abstract][Full Text] [Related]
13. A possible relationship between delayed hypersensitivity and cell-mediated immunity.
Salvin SB; Neta R
Am Rev Respir Dis; 1975 Apr; 111(4):373-7. PubMed ID: 47728
[No Abstract] [Full Text] [Related]
14. Present aspects of the immunology of cancer.
Romieu C; Serrou B
Int Surg; 1974 Aug; 59(8):393-6. PubMed ID: 4604939
[No Abstract] [Full Text] [Related]
15. Need for immunologic stimulators during immunosuppression produced by major cancer surgery.
Cole WH; Humphrey L
Ann Surg; 1985 Jul; 202(1):9-20. PubMed ID: 3893336
[TBL] [Abstract][Full Text] [Related]
16. [Nonspecific active stimulation of the immune system in the combined treatment of rectal cancer].
Kikot' VA; Dziubko NIa
Vrach Delo; 1989 Jul; (7):46-8. PubMed ID: 2800496
[TBL] [Abstract][Full Text] [Related]
17. Ontogeny and regulation of the immune response in the chicken.
Tempelis CH
Prog Vet Microbiol Immunol; 1988; 4():1-20. PubMed ID: 3078863
[No Abstract] [Full Text] [Related]
18. BCG in cancer and leukemia treatment and prophylaxis-A review.
Rosenthal SR
J Med; 1975; 6(3-4):193-212. PubMed ID: 1104732
[TBL] [Abstract][Full Text] [Related]
19. Suppressor factors: potential for immunotherapy.
Krakauer RS; Clough JD
Immunopharmacology; 1980 Jun; 2(3):271-84. PubMed ID: 6160117
[No Abstract] [Full Text] [Related]
20. Specific immunity. 1.
Dawson M
Nurs Times; 1988 May 4-10; 84(18):73-6. PubMed ID: 3260029
[No Abstract] [Full Text] [Related]
[Next] [New Search]
